COL4A1 Promotes Gastric Cancer Progression by Regulating Tumor Invasion, Tumor Microenvironment and Drug Sensitivity

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Collagen type IV alpha 1 chain (COL4A1) is a potential biomarker in Gastric Cancer (GC).
• Its precise role in GC tumors and the tumor microenvironment (TME) requires further elucidation.
• Understanding COL4A1's function is crucial for developing targeted GC therapies.

Purpose of the Study:

• To investigate the prognostic significance of COL4A1 in Gastric Cancer.
• To explore the impact of COL4A1 on tumor progression, immune infiltration, and drug sensitivity.
• To establish a predictive model for GC patient outcomes based on COL4A1 expression.

Main Methods:

• Analysis of COL4A1 expression in TCGA database and GC tissues.
• Validation using immunohistochemistry, Q-PCR, and western blot.
• Functional assays including proliferation, colony formation, invasion, and migration assays.
• Bioinformatic analysis of immune infiltration and drug sensitivity.
• Development of a prognostic nomogram model.

Main Results:

• COL4A1 is significantly overexpressed in GC tissues, correlating with poor prognosis.
• COL4A1 knockdown inhibits GC cell invasion and migration but not proliferation.
• COL4A1 expression is negatively associated with antitumor immunity and positively with multidrug resistance.
• A nomogram incorporating COL4A1 accurately predicts patient outcomes.

Conclusions:

• COL4A1 serves as a significant prognostic biomarker in Gastric Cancer.
• COL4A1 promotes GC progression, enhances multidrug resistance, and suppresses antitumor immunity.
• COL4A1 represents a promising therapeutic target for Gastric Cancer treatment.